Classified in: Health,
BusinessSubjects: NPT,
NAT
BLUE CROSS BLUE SHIELD OF MASSACHUSETTS EXPEDITES ACCESS TO CARE FOR ALABAMA AND GEORGIA MEMBERS AFFECTED BY SEVERE WEATHER
BOSTON, Jan. 17, 2023 /PRNewswire/ -- In response to severe weather in Alabama and Georgia, Blue Cross Blue Shield of Massachusetts (Blue Cross) is expediting access to care for members who may be affected.
Blue Cross has more than 22,000 members living in areas under states of emergency. The company is working to ensure those members can access health services and medications quickly and in locations convenient to them.
Effective immediately and for the duration of the emergency declaration, Blue Cross is allowing:
- Early refills of any prescription medication
- Affected members to use Well Connection, the health plan's dedicated telehealth platform, to access medical and mental health services free of cost, with no copayments or deductible with the code BCBSMA136.
(Note: Only members with Blue Cross' telehealth benefit will be able to access Well Connection and only via My Blue)
About Blue Cross Blue Shield of Massachusetts
Blue Cross Blue Shield of Massachusetts (bluecrossma.org) is a community-focused, tax-paying, not-for-profit health plan headquartered in Boston. We are committed to the relentless pursuit of quality, equitable and affordable health care with an unparalleled consumer experience. Consistent with our promise to always put our members first, we are rated among the nation's best health plans for member satisfaction and quality. Connect with us on Facebook, Twitter, YouTube, and LinkedIn.
SOURCE Blue Cross Blue Shield of Massachusetts
These press releases may also interest you
at 20:45 |
|
|
The "Cough And Cold Preparations Global Market Opportunities And Strategies To 2032" report has been added to ResearchAndMarkets.com's offering.
The cold and cough preparations market reached a value of nearly $66,754.2 million in 2022, having...
|
at 20:25 |
|
|
Trialbee, known for its Honey platform and hyper-targeted global patient recruitment, today announced a strategic partnership with Savvy Cooperative, the first patient-owned platform that empowers patients to use their health experiences to advance...
|
at 20:05 |
|
|
USANA Hong Kong was recently recognized as a top brand for calcium supplements by market research giant Euromonitor International. This distinction is based on market research of USANA's MagneCal D supplement and its retail value sales data compared...
|
at 20:00 |
|
|
JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced that as of March 29, 2023, the company has conducted 13 clinical...
|
at 20:00 |
|
|
ImmVira announced that its oncolytic virus product MVR-C5252 targeting malignant glioma obtained the approval from National Medical Products Administration ("NMPA") for Phase I clinical trial in China on March 29, 2023. Previously, MVR-C5252 also...
|
at 19:40 |
|
|
Greenbrook TMS Inc. ("Greenbrook" or the "Company") announced today the Company's potential delay in the filing of its annual report on Form 20-F for the year ended December 31, 2022 (the "Annual Report") beyond the prescribed filing deadline in...
|
|
|
|
News published on 17 january 2023 at 13:15 and distributed by: